Media & Press
-
Phebra Establishes New Subsidiary In Canada And Announces Marketing Approval For IV Arsenic Trioxide Solution
May 2019
-
Phebra Expands Head Office
March 2019
-
Phebra Launches New Brand of Phosphate Tablets
December 2018
-
Phebra Announces UK Subsidiary Company
November 2018
-
Oral Arsenic Formulation for Treatment of Acute Promyelocytic Leukaemia (APL)
April 2018
-
Phebra Welcomes PBS Listing of Benzatropine Injection
March 2018
-
Phebra Welcomes PBS Listing of Narcan® Injection
February 2018
-
New Study Shows Benefits of Caffeine For Pre-Term Babies
July 2017
-
Sodium Bicarbonate US Supply Agreement
January 2017
-
Phebra Welcomes PBS Listing for Leukaemia Treatment
April 2016